Celebrex and bextra

Lawsuit vs Pfizer over Celebrex, Bextra safety is revived

The settlement resolves a lawsuit filed by investors in 2004 accusing the company of leaving them in the dark about risks associated with Celebrex and Bextra, Reuters reports.

Pfizer $900 Million Celebrex Bextra Settlement

Law360, New York (August 2, 2016, PM EDT) -- Pfizer Inc.

Pfizer Settles Claims Over <strong>Celebrex</strong>, <strong>Bextra</strong> - WSJ

Pfizer to Fork Over 486 Million to Settle Lawsuit Over Celebrex Bextra

N) on Tuesday said it has reached a $486 million settlement of litation accusing it of causing b losses for shareholders by concealing safety risks associated with its Celebrex and Bextra pain-relieving drugs.

Pfizer Settles Claims Over Celebrex, Bextra - WSJ

Pfizer, the world’s largest drug company, has agreed in principle to an $894 settlement for the painers, Celebrex and Bextra.


Celebrex and bextra:

Rating: 90 / 100

Overall: 99 Rates